Menu
Home
Print
Endometrium Tumour Biomarker Test, HER2
Alternative Names/Synonyms
Solid Tumour Biomarker Testing,
Serous Endometrial Carcinoma, Endometrial, HER2, IHC, ISH
Laboratory
Anatomical Pathology
Sub-section
Surgical Pathology
Ordering Instructions, Requisition
Pathology Consultation and Biomarker Requisition
https://www.mountsinai.on.ca/care/pathology/laboratory-forms-and-requisitions/pathology-consult-requisition
Clinical Significance (If applicable)
Serous (high grade/advanced) endometrial carcinoma where HER2 directed therapy is being considered.
Biomarker: HER2 - IHC/ISH
Specimen Requirements (Sample Type)
Formalin fixed paraffin embedded block or tissue sections cut at 4 microns mounted on "Superfrost Plus" charged slides.
Cause for Rejection
Specimen Acceptability and Transport Guidance
Instrument, Methodology
Dako Omnis
References
https://www.cancercareontario.ca/en/guidelines-advice/treatment-modality/pathology-laboratory-testing/genetic-testing-resources
Test Availability
Monday to Friday; 8 am to 5 pm
Reference Ranges
Please refer directly to the Pathology Report
Laboratory Contact Information
Tel: (416) 586-4800 extension 4457
Fax: (416) 586-8628
Email: PLMconsults@sinaihealth.ca
© 2024 Sinai Health. All rights reserved.